| Drug Name |
Hydroquinone |
| Drug ID |
BADD_D01097 |
| Description |
Hydroquinone is a topical lightening product found in OTC products, and is used to correct skin discoloration associated with disorders of hyperpigmentation including melasma, post-inflammatory hyperpigmention, sunspots, and freckles. It can be used alone, but is more frequently found in combination with other agents such as alpha-hydroxy acids, corticosteroids, retinoids, or sunscreen.
Hydroquinone has come under scrutiny due to several complications associated with its use, including dermal irritation, exogenous onchronosis, and carginogenicity. As a result of these concerns, hydroquinone has been banned in the EU and UK. |
| Indications and Usage |
Hydroquinone is used as an OTC topical lightening agent for disorders of hyperpigmentation including melasma, post-inflammatory hyperpigmention, sunspots and freckles. |
| Marketing Status |
approved; investigational |
| ATC Code |
D11AX11 |
| DrugBank ID |
DB09526
|
| KEGG ID |
D00073
|
| MeSH ID |
C031927
|
| PubChem ID |
785
|
| TTD Drug ID |
D03UOT
|
| NDC Product Code |
51552-0066; 50268-343; 50405-800; 62032-106; 63742-025; 68071-2748; 24689-101; 42851-036; 62991-1196; 62032-100; 62032-101; 62032-122; 71804-231; 75834-137; 76420-160; 69367-174; 72251-005; 62032-105; 71221-995; 71421-801; 49452-3620; 42851-035; 42851-184; 81097-107; 60767-8992; 30815-0040; 42851-038; 42851-039; 51927-1124; 68634-006; 72891-0511; 42192-151; 38779-0075; 72957-004; 50218-009; 51927-0035; 10135-724; 42582-700; 42851-037 |
| UNII |
XV74C1N1AE
|
| Synonyms |
hydroquinone | p-benzenediol | 1,4-dihydroxybenzene | 1,4-benzenediol | beta-quinol | Hidroquin | Hidroquinona Isdin | hydroquinone, copper (1+) salt | hydroquinone, lead (2+) salt (2:1) | hydroquinone, monocopper (2+) salt | Licostrata | Lustra | Melanasa | Melanex | Melpaque | Melquin | Neostrata HQ | Phiaquin | Artra | Eldopaque | Eldoquin | Ultraquin | Solaquin | Esoterica | Hidroquilaude |
